Oscar Health (OSCR) Shares Surge 7.43% Following ACA Subsidy Bill Passage
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 15 2026
0mins
Source: Benzinga
- Legislative Boost: The U.S. House of Representatives' passage of a bill extending ACA subsidies has propelled Oscar Health's stock up 7.43% to $17.93, significantly enhancing investor confidence and improving the company's outlook.
- Barclays Upgrade: Barclays upgraded Oscar Health from Underweight to Equal-Weight, raising its price target from $13 to $18, reflecting a more favorable outlook for the company and further fueling the stock's surge.
- Market Recovery: Oscar Health is currently trading 13.8% above its 20-day simple moving average, indicating strong short-term performance, with a 16.29% increase over the past 12 months, approaching its 52-week highs, suggesting a positive long-term trend.
- Earnings Anticipation: Investors are keenly awaiting the upcoming earnings report on February 10, with an estimated EPS loss of 89 cents and projected revenue of $3.16 billion, indicating significant year-over-year growth and potential improvements in profitability.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like OSCR with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OSCR is 17.04 USD with a low forecast of 11.00 USD and a high forecast of 25.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
1 Buy
4 Hold
2 Sell
Hold
Current: 14.870
Low
11.00
Averages
17.04
High
25.00
Current: 14.870
Low
11.00
Averages
17.04
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oscar Health Shares Decline Amid Medicare Update
- Medicare Impact: The Trump administration's proposed 2027 Medicare Advantage payment changes result in a mere 0.09% average increase, drastically below Wall Street's 4%-6% expectations, putting Oscar Health under pressure to manage rising medical costs effectively.
- Industry Leader's Earnings Drag: UnitedHealth Group reported a medical care ratio near 92% for Q4, up 340 basis points year-over-year, indicating higher-than-expected medical utilization, which amplifies concerns about Oscar Health's cost trends.
- Stock Trend Analysis: Oscar Health's shares are currently trading 6.8% below their 20-day simple moving average and 14.2% below their 100-day average, indicating a bearish trend in the short term, with a 12-month decline of 7.88% reflecting ongoing market struggles.
- Future Earnings Outlook: Investors anticipate a loss of 89 cents per share in the upcoming earnings report on February 10, with revenue estimates at $3.16 billion, indicating growth but also raising concerns about increasing losses that could affect market confidence.
Continue Reading
Freeport-McMoran (FCX) Options Volume Hits 99,904 Contracts, 55.2% of Average Daily Volume
- Active Options Trading: Freeport-McMoran (FCX) has seen options trading volume reach 99,904 contracts today, equivalent to approximately 10 million shares, representing 55.2% of its average daily trading volume over the past month, indicating a significant increase in market interest.
- High Strike Call Options: Among FCX options, the $60 strike call option expiring on February 20, 2026, has particularly high volume with 8,172 contracts traded today, representing about 817,200 underlying shares, suggesting a bullish sentiment among investors regarding future price increases.
- Halliburton Options Activity: Concurrently, Halliburton (HAL) has recorded an options trading volume of 73,129 contracts today, equivalent to approximately 7.3 million shares, which accounts for 54.6% of its average daily trading volume over the past month, reflecting strong market activity for the stock.
- Bullish Call Options: For HAL, the $35 strike call option expiring on March 20, 2026, has seen a trading volume of 22,340 contracts today, representing around 2.2 million underlying shares, indicating investor optimism about the stock's future performance.
Continue Reading